About News News Subscribe Economics Advocacy Democracy Leadership Racial Justice and Equity (-) Health Policy Facet Area of Focus - News Sebastian Tello Trillo Brooke Lehmann Kirsten Gelsdorf Margaret Foster Riley Noah Myung Sophie Trawalter Timothy L. Davis Adam Leive Andy Ortiz Andy Ortiz Bala Mulloth Benjamin Castleman Daphna Bassok David Leblang Jeanine Braithwaite Lucy Bassett Pam Cipriano Raymond C. Scheppach Sarah Turner (-) Christopher J. Ruhm (-) Michael D. Williams Facet People - News Facet UVA Partner - News Research and Commentary Facet News Type - News Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more Feb 15, 2021 Williams: Public Option in Biden Plan Could Change the Face of US Health Care Health Policy Democracy President Biden issued ten executive orders to fight COVID-19 on his first day in office, but his health care platform extends far beyond coronavirus. In an article for The Conversation, Batten’s Michael Williams explores the sweeping health care reforms proposed by the Biden administration and the significant impact they could have on Americans. Read in The Conversation May 14, 2020 Advocates say Reopening Plan puts Communities of Color at Risk Advocacy Health Policy Batten's Dr. Michael Williams acknowledges that Virginia Governor Ralph Northam is under pressure to reopen, but says the state isn’t ready yet. "To be able to do it safely, I think additional things need to be in place that are not necessarily in place for all members of our society." Listen on WVTF Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more Mar 03, 2020 The Problem with Health Care Price Transparency: We Don’t Have Cost Transparency Health Policy It's not the price of health care that should concern us. It's the cost. There's a distinction, and it matters. Batten's Michael Williams explains why. Read in The Conversation Stay Up To Date with the Latest Batten News and Events Subscribe
Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more
May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill
May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more
Feb 15, 2021 Williams: Public Option in Biden Plan Could Change the Face of US Health Care Health Policy Democracy President Biden issued ten executive orders to fight COVID-19 on his first day in office, but his health care platform extends far beyond coronavirus. In an article for The Conversation, Batten’s Michael Williams explores the sweeping health care reforms proposed by the Biden administration and the significant impact they could have on Americans. Read in The Conversation
May 14, 2020 Advocates say Reopening Plan puts Communities of Color at Risk Advocacy Health Policy Batten's Dr. Michael Williams acknowledges that Virginia Governor Ralph Northam is under pressure to reopen, but says the state isn’t ready yet. "To be able to do it safely, I think additional things need to be in place that are not necessarily in place for all members of our society." Listen on WVTF
Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more
Mar 03, 2020 The Problem with Health Care Price Transparency: We Don’t Have Cost Transparency Health Policy It's not the price of health care that should concern us. It's the cost. There's a distinction, and it matters. Batten's Michael Williams explains why. Read in The Conversation